Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT02084888 Completed - Clinical trials for Coronary Artery Disease

Prognostic Impact of Chronic Total Occlusions

Start date: January 2005
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine the prognostic impact of the presence of chronic total occlusions (CTO) of the coronary arteries in patients undergoing coronary angiography and PCI.

NCT ID: NCT02083146 Terminated - Clinical trials for Coronary Artery Disease (CAD)

C1q/TNF-related Proteins in Coronary Artery Disease

Start date: March 2011
Phase:
Study type: Observational

Now, adipose tissue is established as an active endocrine organ that controls systemic energy homeostasis by secretion of adipokines. Recently, members of the C1q/tumor necrosis factor-related protein (CTRP) family have been reported to share structural homology with adiponectin. To date, 15 CTRP family members have been found that might play major roles in metabolism and inflammation. The investigators tried to clarify the relationship between CTRP family and coronary artery disease (CAD) in Korean men and women.

NCT ID: NCT02082483 Completed - Clinical trials for Coronary Artery Disease

Coronary Artery Disease Screening in Kidney Transplant Candidates

CADScreening
Start date: November 2014
Phase: N/A
Study type: Interventional

Kidney transplant candidates are at very high risk for coronary artery disease (CAD). The optimal strategy to monitor and maintain the cardiac fitness of patients awaiting kidney transplantation is unknown. Currently patients undergo annual testing; however, screening for CAD may increase morbidity and mortality by: 1. exposing patients to the risk of angiography and revascularization procedures 2. delaying or excluding patients from life saving transplantation. Before proceeding with a definitive study to determine whether screening is necessary, feasibility will be determined in this pilot study.

NCT ID: NCT02081976 Completed - Coronary Disease Clinical Trials

Periodontal Therapy in a Primary Prevention of Cardiovascular Disease

Start date: April 2013
Phase: Phase 2
Study type: Interventional

Cardiovascular diseases (CVD) are still considered the main cause of mortality and morbidity all over the world. In the last years, efforts have been made to define more effective therapeutic and preventive strategies.Periodontal diseases have been considered a probable risk factor for CVD with a great amount of evidence from observational studies. Although there are some interventional studies evaluating the systemic effects of periodontal therapy, there is little information regarding the impact of periodontal treatment on the prevention of cardiovascular events. To the best of our knowledge, there are no randomized controlled trials published to date assessing the effect of periodontal therapy in primary prevention of CVD.

NCT ID: NCT02081443 Completed - Clinical trials for Coronary Artery Disease

In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated Patients

Start date: April 2014
Phase: N/A
Study type: Interventional

Cangrelor is a potent intravenous P2Y12 receptor inhibitor with rapid onset and offset of action associated with a greater reduction in ischemic events, including stent thrombosis, in patients undergoing stent procedures who have not been pretreated with clopidogrel. In vitro investigations have shown cangrelor to be associated with more rapid, potent, and consistent platelet inhibition in patients on maintenance prasugrel therapy exposed to a re-loading dose of prasugrel. However, if cangrelor exerts similar effects in ticagrelor treated patients remain unknown. The aim of the present study is to evaluate the effects on platelet function achieved after in vitro incubation with cangrelor in patients on ticagrelor maintenance dose who receive a loading dose of ticagrelor.

NCT ID: NCT02079194 Active, not recruiting - Clinical trials for Coronary Artery Disease

Comparison Between P2Y12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES

SMART-CHOICE
Start date: March 18, 2014
Phase: N/A
Study type: Interventional

To compare the efficacy and safety of clopidogrel monotherapy versus aspirin plus P2Y12 antagonist following 3-month of DAPT in patients undergoing PCI with DES.

NCT ID: NCT02077218 Completed - Hypertension Clinical Trials

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Start date: February 2014
Phase: N/A
Study type: Interventional

This pilot clinical trial studies computed tomography (CT) scans and biomarker analysis in diagnosing coronary artery disease (CAD) in patients who have undergone a stem cell transplant but have no symptoms of CAD. CAD is a disease in which there is a narrowing or blockage of the coronary arteries (blood vessels that carry blood and oxygen to the heart) and patients who have undergone a stem cell transplant are at an especially high risk for CAD. A CT scan involves a series of detailed pictures of areas inside the body taken from different angles. The pictures are created by a computer linked to an x-ray machine. Studying samples of blood from patients who have undergone a stem cell transplant in the laboratory may help doctors identify and learn more about biomarkers related to CAD. Using a CT scan in combination with biomarker analysis may be a better and less-invasive way to diagnose CAD.

NCT ID: NCT02076802 Recruiting - Clinical trials for Cardiovascular Disease

Regular Physical Exercise and Salt Diet on Coronary Artery Disease in Patients With Prehypertension(RESTRAIN Pre-HT)

Start date: December 2012
Phase: N/A
Study type: Observational [Patient Registry]

The epidemic data shows that prehypertension is associated with cardiovascular disease, and heavy dietary salt intake could improve the developing of hypertension. We detected the risk factors of coronary atherosclerosis of prehypertensive patients with different levels of salt intake. The aim of this multicenter prospective, randomized controlled study is to evaluate regular physical exercise and salt diet effects on progression of coronary artery disease in patients with prehypertension.

NCT ID: NCT02076516 Recruiting - Clinical trials for Coronary Artery Disease

Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)

PILOT-SECRET
Start date: October 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the CORACTO® (Rapamycin®-Eluting coronary stent delivery system) for the treatment of up to two de novo lesions or restenotic post-PTCA (non-stented) lesions located in up to two epicardial native coronary arteries (maximum one lesion per vessel) suitable for treatment with stents from 2.5 to 4.0 mm in diameter < than 15 mm suitable for treatment with a single CORACTO® stent in a population of 100 patients.

NCT ID: NCT02074371 Completed - Clinical trials for Coronary Artery Disease

Postoperative Respiratory Depression After Cardiac Surgery

CABG PRD
Start date: January 2012
Phase: N/A
Study type: Observational

Coronary artery bypass graft surgery (CABG) is associated with postoperative respiratory depression. In this study we aimed at investigating perioperative parameters that could predict the nadir of postoperative respiratory function impairment.